Biomarkers predict brain tumor's response to therapy
Tuesday, June 23, 2009 - 12:42
in Health & Medicine
A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.
Read the whole article on Physorg
More from Physorg
Related
- Biomarkers predict brain tumor's response to therapyTue, 23 Jun 2009, 13:42:50 EDT
- Study identifies biomarker that safely monitors tumor response to new brain cancer treatmentWed, 1 Jul 2009, 0:50:29 EDT
- New approach to gene therapy may shrink brain tumors, prevent their spreadThu, 25 Sep 2008, 11:57:08 EDT
- Tumor-attacking virus strikes with 'one-two punch'Tue, 1 Dec 2009, 11:24:44 EST
- Biomarker predicts disease recurrence in colorectal cancerTue, 17 Feb 2009, 18:36:07 EST